The seven-year unwinding of the billion-dollar Medical Capital Holdings Ponzi scheme is over, with swindled investors receiving more than $400 million.
Last Friday in U.S. District Court, Central District of California, Judge David O. Carter issued his final judgment in the case, which began in July 2009 when the Securities and Exchange Commission sued Medical Capital for fraud.
That lawsuit proved to be the death knell for dozens of small and mid-sized independent broker-dealers that sold the Medical Capital private placements and other private deals that soured. Swamped by the cost of investor complaints, many of the firms that sold the private placements closed.
Mr. Carter ordered that Medical Capital Holdings and other related companies and executives pay disgorgement of $831 million.
According to court documents, close to 9,000 Medical Capital investors were owed approximately $1.08 billion, while the cash on hand at the company was $2.9 million. Investors have recovered $432 million, according to
the court appointed receiver, Thomas Seaman. That includes $151 million recovered and distributed by the receiver; $180 million from the bond indenture trustees, or
banks; and $101 million from
broker-dealers.
Harmed MedCap investors received about 40 cents on the dollar, according to those figures. Investors in Ponzi schemes historically have gotten back far less, or five to 10 cents on the dollar.
From 2003 to 2009, Medical Capital raised almost $2 billion through a network of independent broker-dealers, purportedly to buy discounted medical receivables such as unpaid doctor or hospital bills that Medical Capital would then collect at full price.
